As states across the US begin to cautiously look towards re-opening and many hospitals’ ICU capacities level out and elective surgeries resume, the wheels of progress keep turning. This month, we look at what the federal government is doing…

Federally Qualified Health Centers (FQHCs) operate on a not-for-profit basis and serve a disproportionate share of our nation’s vulnerable population – patients who often struggle with interconnected disparities that affect their health,…

CMS addresses 340B duplicate discounts Under the provisions of the 340B law, pharmaceutical manufacturers are not required to offer a drug at the 340B discount rate to covered entities and pay rebates to state Medicaid programs for the same…

In the past several weeks, COVID-19 has affected us all personally and professionally in ways we never expected. Some of the changes that have taken place have had a profound effect on covered entities, including drug shortages, 340B enrollment…

To help maintain 340B Program integrity, HRSA has the authority to audit covered entities for compliance with the program requirements. At its core, the audit looks for accuracy of the Office of Pharmacy Affairs Information System (OPAIS), record…

The American Pharmacists Association (APhA) 2020 Annual Meeting & Expo was scheduled to take place March 20-23 in National Harbor, Maryland. Due to the current COVID-19 pandemic, the live event was canceled, but the House of Delegates meeting…

Dear readers, We understand that the news foremost on everyone’s minds at the moment is COVID-19 and the wellbeing of loved ones and the community. Sentry applauds the efforts of everyone working to overcome this challenge, including physicians,…

This month, we take a look at the bracket, which includes the latest MedPAC committee meeting, state legislation that impacts drug prices and 340B, the Supreme Court takes up the ACA case and CMS’ planned survey for covered entities regarding…

With the new year and the new decade now upon us, Sentry is making a concerted effort to attend and present at key conferences throughout 2020, to continue being a voice for covered entities. We began with the 340B Coalition Winter Conference,…